Hypoglycaemia-induced morbidity and mortality has emerged as one of the major unintended consequences of efforts to achieve optimal glucose control in individuals with insulin-treated diabetes mellitus. A study by Jackson and colleagues offers novel insights into therapies to mitigate the adverse consequences hypoglycaemic events have on the central nervous system.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993).
[No authors listed]. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46, 271–286 (1997).
Sommerfield, A. J., Deary, I. J., McAulay, V. & Frier, B. M. Moderate hypoglycemia impairs multiple memory functions in healthy adults. Neuropsychology 17, 125–132 (2003).
Garg, S. K. et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol. Ther. 19, 155–163 (2017).
Martin-Timon, I. & Del Canizo-Gomez, F. J. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J. Diabetes 6, 912–926 (2015).
Jackson, D. A. et al. Prevention of severe hypoglycemia-induced brain damage and cognitive impairment with verapamil. Diabetes https://doi.org/10.2337/db18-0008 (2018).
van Zwieten, P. A. Protective effects of calcium antagonists in different organs and tissues. Am. Heart J. 125, 566–571 (1993).
Moretti, A., Ferrari, F. & Villa, R. F. Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol. Ther. 146, 23–34 (2015).
Suh, S. & Kim, J. H. Glycemic variability: how do we measure it and why is it important? Diabetes Metab. J. 39, 273–282 (2015).
Hwang, J. J. et al. Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia. J. Clin. Invest. 128, 1485–1495 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Hwang, J.J., Sherwin, R.S. Verapamil is a potential therapy for hypoglycaemic brain injury. Nat Rev Endocrinol 14, 443–444 (2018). https://doi.org/10.1038/s41574-018-0056-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-018-0056-7
